TW200420290A - Methods for the treatment, prevention and management of macular degeneration - Google Patents
Methods for the treatment, prevention and management of macular degenerationInfo
- Publication number
- TW200420290A TW200420290A TW092130487A TW92130487A TW200420290A TW 200420290 A TW200420290 A TW 200420290A TW 092130487 A TW092130487 A TW 092130487A TW 92130487 A TW92130487 A TW 92130487A TW 200420290 A TW200420290 A TW 200420290A
- Authority
- TW
- Taiwan
- Prior art keywords
- methods
- macular degeneration
- prevention
- management
- treatment
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title 1
- 229940118135 JNK inhibitor Drugs 0.000 abstract 1
- 239000012825 JNK inhibitor Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000000554 physical therapy Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42289602P | 2002-10-31 | 2002-10-31 | |
| US10/699,105 US20040092568A1 (en) | 2002-10-31 | 2003-10-30 | Methods for the treatment, prevention and management of macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200420290A true TW200420290A (en) | 2004-10-16 |
Family
ID=32233518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092130487A TW200420290A (en) | 2002-10-31 | 2003-10-31 | Methods for the treatment, prevention and management of macular degeneration |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040092568A1 (https=) |
| EP (1) | EP1565188A2 (https=) |
| JP (1) | JP2006507307A (https=) |
| KR (1) | KR20050061596A (https=) |
| AU (1) | AU2003286802A1 (https=) |
| BR (1) | BR0315939A (https=) |
| CA (1) | CA2504028A1 (https=) |
| MX (1) | MXPA05004550A (https=) |
| NZ (1) | NZ540187A (https=) |
| TW (1) | TW200420290A (https=) |
| WO (1) | WO2004041191A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984652B2 (en) * | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| ES2284308B1 (es) * | 2005-03-08 | 2008-08-01 | Bsh Electrodomesticos España, S.A. | Tambor para maquina lavadora de ropa. |
| CA2663545A1 (en) * | 2006-09-19 | 2008-03-27 | Phylogica Limited | Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
| WO2010009166A1 (en) | 2008-07-14 | 2010-01-21 | Gilead Colorado, Inc. | Oxindolyl inhibitor compounds |
| US8124764B2 (en) | 2008-07-14 | 2012-02-28 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitor compounds |
| CA2729909A1 (en) | 2008-07-14 | 2010-01-21 | Gilead Sciences, Inc. | Imidazolyl pyrimidine inhibitor compounds |
| CN102123987A (zh) | 2008-07-28 | 2011-07-13 | 吉里德科学公司 | 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物 |
| JP5808107B2 (ja) | 2008-12-17 | 2015-11-10 | 学校法人慶應義塾 | 細胞特異的能動集積性を有する光線力学療法剤 |
| WO2010113753A1 (ja) * | 2009-03-30 | 2010-10-07 | 参天製薬株式会社 | ＪＮＫ（ｃ－Ｊｕｎアミノ末端キナーゼ）阻害ペプチドを用いた網膜疾患の予防または治療剤、網膜疾患の予防または治療方法、ならびに、その使用 |
| KR20120031170A (ko) | 2009-06-08 | 2012-03-30 | 길리애드 사이언시즈, 인코포레이티드 | 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물 |
| US8283357B2 (en) | 2009-06-08 | 2012-10-09 | Gilead Sciences, Inc. | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds |
| CN115784993A (zh) * | 2022-11-23 | 2023-03-14 | 四川大学华西医院 | 一种3-氨基吲唑类化合物的制备及其治疗帕金森病的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075116A (en) * | 1989-04-20 | 1991-12-24 | Lahaye Laboratories, Inc. | Composition and method for treatment of macular degeneration |
| KR20080028516A (ko) * | 1999-08-19 | 2008-03-31 | 시그널 파머슈티컬스 인크 | Ｊｎｋ억제제로서의 피라졸로안트론과 그 유도체 및 이를함유하는 조성물 |
| US6204270B1 (en) * | 1999-11-12 | 2001-03-20 | Eyal S. Ron | Ophthalmic and mucosal preparations |
| JP4739632B2 (ja) * | 2000-02-05 | 2011-08-03 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｅｒｋのインヒビターとして有用なピラゾール組成物 |
| US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| US7129242B2 (en) * | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
-
2003
- 2003-10-30 US US10/699,105 patent/US20040092568A1/en not_active Abandoned
- 2003-10-31 CA CA002504028A patent/CA2504028A1/en not_active Abandoned
- 2003-10-31 NZ NZ540187A patent/NZ540187A/en unknown
- 2003-10-31 BR BR0315939-6A patent/BR0315939A/pt not_active IP Right Cessation
- 2003-10-31 TW TW092130487A patent/TW200420290A/zh unknown
- 2003-10-31 MX MXPA05004550A patent/MXPA05004550A/es unknown
- 2003-10-31 JP JP2004550330A patent/JP2006507307A/ja active Pending
- 2003-10-31 AU AU2003286802A patent/AU2003286802A1/en not_active Abandoned
- 2003-10-31 KR KR1020057007658A patent/KR20050061596A/ko not_active Withdrawn
- 2003-10-31 EP EP03778016A patent/EP1565188A2/en not_active Withdrawn
- 2003-10-31 WO PCT/US2003/034662 patent/WO2004041191A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006507307A (ja) | 2006-03-02 |
| NZ540187A (en) | 2008-03-28 |
| US20040092568A1 (en) | 2004-05-13 |
| WO2004041191A3 (en) | 2004-12-02 |
| BR0315939A (pt) | 2005-09-13 |
| KR20050061596A (ko) | 2005-06-22 |
| AU2003286802A1 (en) | 2004-06-07 |
| EP1565188A2 (en) | 2005-08-24 |
| MXPA05004550A (es) | 2005-07-26 |
| WO2004041191A2 (en) | 2004-05-21 |
| CA2504028A1 (en) | 2004-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| WO2005044178A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| SG148202A1 (en) | Quinazolinone compounds as anticancer agents | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| MXPA05004778A (es) | Metodos de uso y composiciones que contienen compuestos inmunomoduladores para el tratamiento y manejo de enfermedades mieloproliferativas. | |
| TW200507833A (en) | Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents | |
| MX2007005570A (es) | Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos. | |
| TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
| TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
| WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| WO2006047716A3 (en) | Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| WO2004037207A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| WO2004096118A3 (en) | Composition for improving cognition and memory | |
| EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
| NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
| TW200503683A (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| WO2004041190A3 (en) | Composition for the treatment of macular degenration | |
| MX2007005040A (es) | Metodos y composiciones usando moduladores de pde4 para el tratamiento y manejo de lesion al sistema nervioso central. | |
| WO2005039497A3 (en) | Methods and compositions comprising thalidomide for treatment of fibromyalgia | |
| ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
| WO2005046594A3 (en) | Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders | |
| Dhanda et al. | Patterns of treatment of osteoradionecrosis with hyperbaric oxygen therapy in the United Kingdom | |
| MX2010005009A (es) | Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales. | |
| WO2004041181A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |